Atrial Fibrillation Risk With Cancer Drugs Underestimated

Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials, and so oncologists may underestimate the risk of this adverse event.
Medscape Medical News

source https://www.medscape.com/viewarticle/990547?src=rss